Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
PreOncology today announced the launch of the nation's first medical-grade, oncologist-led cancer prevention and early detection program, introducing an emerging subspecialty of medical oncology ...
In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results